What is the extent of Government funding to facilitate the provision of disability information since 1990; to whom it has been paid; and with what result. [HL 4767]. - Inc figures and ref to Section 64 of the Health Services and Public Health Act 1968.

What is the extent of Government funding to facilitate the provision of disability information since 1990; to whom it has been paid; and with what result. [HL 4767]. - Inc figures and ref to Section 64 of the Health Services and Public Health Act 1968.

What evidence they have on the provision in the North West of mix-funding from local health, employment and social services agencies for helping to rehabilitate those with acquired brain injury back into work; and what advice they have received from the Social Services Inspectorate on this issue. [HL 4290].

What evidence they have on the provision in the North West of mix-funding from local health, employment and social services agencies for helping to rehabilitate those with acquired brain injury back into work; and what advice they have received from the Social Services Inspectorate on this issue. [HL 4290].

Lords debate on unstarred question on what plans they have to improve the care and treatment of patients with hepatitis C.

Lords debate on unstarred question on what plans they have to improve the care and treatment of patients with hepatitis C.

What contributions are made from the National Health Service to hospices; and what proportion this represents of the total cost of the hospice movement, including specialised staff training courses in palliative treatment. [HL 4196]. - Inc figures.

What contributions are made from the National Health Service to hospices; and what proportion this represents of the total cost of the hospice movement, including specialised staff training courses in palliative treatment. [HL 4196]. - Inc figures.

Further to the Written Answer by Lord Hunt of Kings Heath on 2 October 2000 at 616 c203-4, what information they have on differences in the rates of incidence of, and mortality from, prostate cancer in differing racial groups in the area of each National Health Service Trust; which three...

Further to the Written Answer by Lord Hunt of Kings Heath on 2 October 2000 at 616 c203-4, what information they have on differences in the rates of incidence of, and mortality from, prostate cancer in differing racial groups in the area of each National Health Service Trust; which three...

For each of the last five years for which figures are available, how many deaths were recorded respectively in England, Wales and Northern Ireland as the result of (a) multiple sclerosis, (b) CJD, and (c) AIDS; what was the total amount of expenditure by the Government in the United Kingdom...

For each of the last five years for which figures are available, how many deaths were recorded respectively in England, Wales and Northern Ireland as the result of (a) multiple sclerosis, (b) CJD, and (c) AIDS; what was the total amount of expenditure by the Government in the United Kingdom...

Whether they will give a breakdown of how the additional £360 million they are making available to assist people to meet the cost of their residential and nursing home care will be allocated and a similar breakdown of the £900 million they are making available for intermediate care. [HL 3893]....

Whether they will give a breakdown of how the additional £360 million they are making available to assist people to meet the cost of their residential and nursing home care will be allocated and a similar breakdown of the £900 million they are making available for intermediate care. [HL 3893]....

Whether their policy with regard to research into prostate cancer has changed since the Written Answers by the Lord Hunt of Kings Heath on 10 April V612 c17-19WA. [HL 3829]. - Including figures and ref to The NHS Prostate Cancer Programme.

Whether their policy with regard to research into prostate cancer has changed since the Written Answers by the Lord Hunt of Kings Heath on 10 April V612 c17-19WA. [HL 3829]. - Including figures and ref to The NHS Prostate Cancer Programme.